MedCity News March 26, 2024
Marissa Plescia

During a panel discussion on GLP-1s at the Abarca Forward conference, one health executive stressed the importance of a food-as-medicine approach.

Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca Health, a pharmacy benefit manager. MedCity News was invited to host and attend the event. Accommodations for the team were covered by Abarca. However, company officials had no input in editorial coverage.

GLP-1s like Ozempic and Wegovy are making waves for their potential to improve obesity rates. But they shouldn’t be the sole focus when it comes to achieving meaningful and sustainable weight loss, according to one health executive. Rather, there should be a focus on lifestyle...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Conferences / Podcast, Patient / Consumer, Pharma / Biotech, Provider, Trends
Related Articles:
Bird Flu H5N1—What We Know So Far About Its Spread To Cows
Should You Worry About The Bird Flu? Here Are The Concerns
Why You Might Be Responsible For Paying Your Parents’ Medical Debts
What do employees really want out of generative AI?
Covid-19 Pandemic Led To Growing Acceptance Of Doctors Withholding Treatment

Share This Article